Clinical Trial Update: Efficacy Study of SYN006 HFA MDI in Asthma Patients [Phase 2]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 2 efficacy study of SYN006 HFA MDI in asthma patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• SYN006 HFA MDI

Snippet

Sponsor: Intech Biopharm Ltd. | Conditions: Asthma | Phase 2 | Status: COMPLETED